Access to vaccines around the world could get easier thanks to scientists at The University of Texas at Austin who have developed an inexpensive and innovative vaccine delivery method that preserves live viruses, bacteria, antibodies and enzymes without refrigeration.
In that emerging global health threat of COVID-19, University of Oregon researchers saw an opportunity to learn about how people perceive risk around the new coronavirus that causes the COVID-19 illness and how that affects their decision-making, which in turn may help policy-makers better communicate around the crisis.
Researchers at the the University of Southern California found that identifying a metastatic colorectal cancer patient’s Consensus Molecular Subtype (CMS) could help oncologists determine the most effective course of treatment.
Researchers at the University of Southern California are studying bioluminescent deep-sea creatures to illuminate effectiveness of new cancer therapies.
A new study at the University of Southern California shows mental health-related emergency department visits have increased substantially since 2009, a trend driven by large increases in adolescent and young adult visits to the emergency room for behavioral health-related diagnoses.
UCLA researchers have developed an artificial intelligence system that could help pathologists read biopsies more accurately and to better detect and diagnose breast cancer.
A study led by UCLA researchers found that adding ribociclib, a targeted therapy drug, to standard hormone therapy significantly improves overall survival in postmenopausal women with advanced hormone-receptor positive/HER2- breast cancer, one of the most common types of the disease.
Telomerase reverse transcriptase (TERT), an enzyme associated with nearly all malignant human cancers, is even more diverse and unconventional than previously realized, new CU Boulder research finds.
Stanford University data scientists have shown that figuring out a single number can help them find the most dangerous cancer cells.
Immunotherapy has great promise as a cancer treatment, but current therapies only work in some. Now, Stanford researchers are testing the idea that microorganisms in our guts might be the deciding factor.